Trial Profile
The intervention trial of safety and efficacy of once-weekly Trelagliptin switched from daily DPP4 inhibitors for elderly patients with type 2 diabetes
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Mar 2017 New trial record